请使用支持JavaScript的浏览器!
主营:基因芯片、二代测序NGS测序仪及相关测序试剂盒
banner
当前位置: 首页 > 产品中心 > Microarray Kits > Illumina/Infinium OmniZhongHua-8 v1.3 Kit (96 samples)/20004339/1 Ea
公司介绍
Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供最新的产品与应用资讯。Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an en...

Illumina/Infinium OmniZhongHua-8 v1.3 Kit (96 samples)/20004339/1 Ea

Illumina/Infinium OmniZhongHua-8 v1.3 Kit (96 samples)/20004339/1 Ea
  • Illumina/Infinium OmniZhongHua-8 v1.3 Kit (96 samples)/20004339/1 Ea
商品介绍

ProductHighlights:

TheInfiniumOmniZhongHua-8BeadChipdeliversexceptionalcoverageofcommon,intermediate,andrarevariationfoundwithinChinesepopulationsforgenome-wideassociationstudies(GWAS).OptimizedtagSNPcontentfromallthreeHapMapphasesandthe1000GenomesProject(1kGP)hasbeenstrategicallyselectedtocreateapopulation-focusedarrayforthediscoveryofnoveldiseaseandtraitassociationsinChinesepopulations.

TheInfiniumOmniZhongHua-8BeadChipallowsprofilingof>890,000Markerspersample.TheassayisdeployedwithproprietaryBeadArraytechnology,deliveringexceptionallyhighdataqualitywithregardstocallrates(average>99%),reproducibility(>99.9%),andlowsamplerepeatrates.Highsignal-to-noiseratiosandlowoverallnoiselevelsallowforprecise,reliablecallsandcopynumberanalyses.

LearnMoreAboutHumanGenotyping

Specifications:

NumberofMarkersFixedmarkers:878,291,Custommarkeradd-oncapacity:None
SampleThroughput~960samplesperweek
InputQuantity200ngDNA
TechnologyMicroarray
VariantClassSingleNucleotidePolymorphisms(SNPs),GermlineVariants,StructuralVariants,Insertions-Deletions(indels),CopyNumberVariants(CNVs)
SpecializedSampleTypesFFPE
SpeciesCategoryHuman
AutomationCapABIlityLiquidHandlingRobots,Autoloader2.xArrayLoader
SystemCompatibilityiScan
品牌介绍

Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供最新的产品与应用资讯。Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。

As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go

While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination

Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

We now have the ability to sequence at an unprecedented scale. Collectively, this will give us a much deeper understanding of genetics than ever before. We will begin to truly unlock the power of the genome. These advances will trigger a fundamental shift in healthcare and beyond. Medicine will continue to become more preventive and more precise. We will be healthier, longer. We have only just begun.

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics



蚂蚁淘(ebiomall)作为一家生命科学领域的垂直电商平台,公司专注生物医学科研用品的全球导购和品牌推广,为海内外厂方与代理经销商搭建跨境贸易系统和交流平台。产品齐全,200+分类,1000+品牌,500万+产品信息。100%正品,专业售后,到货快,在线下单, 简单轻松,节省科学家宝贵的科研时间。为您竭诚服务!

【订购】蚂蚁淘生物科技  联系方式:4000-520-616

更多产品,更多优惠!请联系我们!

苏州蚂蚁淘生物科技有限公司

免费热线:4000-520-616

官网:https://www.ebiomall.com/



面向转化和临床研究人员的产品
用于Illumina BRCA面板的AmpliSeq

有针对性的研究小组,研究BRCA1BRCA2中的体细胞和种系变异

产品信息图

AmpliSeq用于Illumina癌症热点面板v2

目标研究小组调查了50个与癌症有已知关联的基因的热点区域。

产品信息图

AmpliSeq用于Illumina儿童期癌症研究小组

研究儿童和年轻人中与癌症相关的203个基因的目标小组。

产品信息图

AmpliSeq用于Illumina综合癌症研究小组

靶向小组调查了与癌症有已知关联的409个基因的外显子区域。

产品信息图

用于Illumina全面面板v3的AmpliSeq

靶向DNA和RNA研究小组研究了与多种癌症类型相关的161个基因的变异。

产品信息图

用于Illumina聚焦面板的AmpliSeq

靶向DNA和RNA研究小组研究了与实体瘤相关的52个基因。

产品信息图

AmpliSeq用于Illumina免疫库,TCR beta面板

靶向RNA研究小组可通过对T细胞受体β链重排进行测序来研究T细胞多样性和克隆扩增。

产品信息图

AmpliSeq用于Illumina免疫反应面板

靶向RNA表达小组研究了395个与肿瘤-免疫系统相互作用有关的基因。

产品信息图

AmpliSeq用于Illumina髓样面板

目标小组研究了40个与髓样癌相关的DNA基因,29个RNA融合驱动基因和5个基因表达水平。

产品信息图

AmpliSeq用于Illumina点播

通过从5,000多种预先测试的基因中进行选择,为人类疾病研究提供量身定制的面板设计。

产品信息图

COVIDSeq测试(RUO版本)

这种高通量下一代测序(NGS)分析可检测SARS-CoV-2病毒的RNA。

产品信息图

HumanCytoSNP FFPE-12珠芯片

该BeadChip阵列针对使用福尔马林固定石蜡包埋(FFPE)配对的肿瘤正常样品的细胞遗传学研究进行了优化。

产品信息图

HumanCytoSNP-12珠芯片

这个由12个样本组成的BeadChip阵列可以分析人类基因组中的遗传和结构变异,例如重复,缺失,扩增,复制中性LOH和镶嵌。


自营商城图标
厂家直采
全球直采模式 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔
在线客服
客服电话

4000-520-616

0512-67156496